Entebbe

The trials here

What the trial at this site is about, from its registry record.

Conditions

• HIV

Running trials

• Active, not recruiting

  Long-term Follow-up of Long-acting Cabotegravir (CAB LA) for PrEP (Pre-exposure Prophylaxis) in Participants at Risk of Acquiring HIV (Human Immunodeficiency Virus)

  NCT06134362· Phase 3· ViiV Healthcare· Source